Vitamin D Replacement After Kidney Transplant
NCT00748618 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116
Last updated 2024-10-26
Summary
Vitamin D deficiency accelerates vascular risk progression after kidney transplant.
Conditions
- Kidney Transplantation
- Vitamin D Deficiency
Interventions
- DIETARY_SUPPLEMENT
-
Standard vitamin D3 treatment
10,000 I.U./wk of vitamin D3 orally for 6 months
- DIETARY_SUPPLEMENT
-
High dose vitamin D3 treatment
50,000 I.U./wk of vitamin D3 orally for 6 months
Sponsors & Collaborators
-
University of Nebraska
lead OTHER
Principal Investigators
-
Jennifer L Larsen, MD · University of Nebraska
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-10-01
- Primary Completion
- 2012-04-01
- Completion
- 2023-06-08
Countries
- United States
Study Locations
More Related Trials
-
Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant Patients
NCT00646282 ·Status: TERMINATED ·Phase: PHASE4
-
Vitamin K Supplementation in Patients on Hemodialysis
NCT02324686 ·Status: COMPLETED ·Phase: PHASE2
-
Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients
NCT01173848 ·Status: TERMINATED ·Phase: PHASE3
-
Vitamin D and Cardiac Autonomic Tone in Hemodialysis
NCT01774812 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Trial of Supplemental Vitamin A and Nicotinamide
NCT05702398 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients
NCT03311321 ·Status: UNKNOWN ·Phase: NA
-
Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients
NCT00958451 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Fixed Dose Versus Serum Level-Based Titration Regimen of Vitamin D Supplementation in Dialysis Patients
NCT05434377 ·Status: COMPLETED ·Phase: NA
-
Vitamin D Effect on Calcium Absorption on Persons on Hemodialysis
NCT01325610 ·Status: COMPLETED ·Phase: NA
-
Impact of Vitamin D Therapies on Chronic Kidney Disease
NCT01222234 ·Status: COMPLETED ·Phase: NA
-
Incorporation of Vitamin K Into Uremic Lipoproteins
NCT05360342 ·Status: COMPLETED ·Phase: NA
-
Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease
NCT01835691 ·Status: COMPLETED ·Phase: NA
-
Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury
NCT02962102 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Effects of Vitamin D in Hemodialysis Patients
NCT00686751 ·Status: COMPLETED ·Phase: PHASE2
-
Identification of Markers for Determining the Efficacy of Vitamin D Receptor Activator Therapy in Stage 3/4 CKD Patients
NCT02018133 ·Status: COMPLETED
-
Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy
NCT02278692 ·Status: COMPLETED ·Phase: NA
-
Vitamin D 2 to Dialysis Patients
NCT00535158 ·Status: TERMINATED
-
Vitamin D Repletion in Chronic Kidney Disease
NCT00772772 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
NCT01312441 ·Status: TERMINATED ·Phase: PHASE4
-
Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease
NCT01426724 ·Status: WITHDRAWN ·Phase: NA
-
Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease
NCT02937350 ·Status: COMPLETED ·Phase: PHASE1
-
Vitamin D Repletion in Stone Formers With Hypercalciuria
NCT01295879 ·Status: COMPLETED ·Phase: PHASE4
-
Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers
NCT01237028 ·Status: COMPLETED ·Phase: NA
-
A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation
NCT05549154 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetic Comparison of Vitamin's D2 and D3 in Stage 5 Chronic Kidney Disease Patients on Chronic Hemodialysis
NCT01675557 ·Status: COMPLETED ·Phase: PHASE4